Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.
Microdose GLP OneEvidence Edition · Updated July 20, 2026

Editorial governance

Dr. Parmis Mojarab

Editorial Auditor · Semaglutide Watchdog

Dr. Parmis Mojarab serves as Editorial Auditor. This profile lists only confirmed role information. Additional credential, license, institution, and specialty details are not published here pending independent verification, and no clinical-review authority or medical credential is asserted for this role. The Editorial Auditor reviews published pages for adherence to our editorial standards, evidence policy, and disclosure requirements. This is an editorial-governance function and is distinct from medical review, which is performed by our named medical reviewer and lead clinical reviewer.

Credentials & verification

Dr. Parmis Mojarab — role information
RoleEditorial Auditor
AffiliationSemaglutide Watchdog
Review scopeEditorial-governance review of published pages for adherence to editorial standards, evidence policy, and disclosure requirements. Not medical review.
Credential / licenseNot published here pending independent verification. No clinical-review authority or medical credential is asserted for this role.
FunctionEditorial governance — distinct from medical review, which is performed by our named medical reviewer and lead clinical reviewer.

← All reviewers · Publisher: Microdose GLP One. Only confirmed information is shown. Compounded medications are not FDA approved.